The Ensign Group, Inc. vs Johnson & Johnson
ENSG vs JNJ — side-by-side comparison from reported financials. ENSG leads 5, JNJ leads 6 of 11 comparable metrics.
The Ensign Group, Inc.
ENSG · Healthcare
$171.80+0.18%Solid
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | ENSG | JNJ |
|---|---|---|
| Price | $171.80 | $261.79 |
| Market cap | $10.0B | $631B |
| Revenue (TTM) | $5.49B | $97.9B |
| Revenue growth | +18.7% | +5.6% |
| Net margin | 6.9% | 21.5% |
| Free cash flow | $608M | $22.2B |
| Net cash (debt) | ($1.63B) | ($27.8B) |
| 1-year price return | -2.3% | +37.0% |
| P/E | 26.4 | 29.9 |
| P/E vs own history (cheap-side %) | 48% | 16% |
| Dividend yield | 0.15% | 2.00% |
| Return on equity | 17% | 26% |
| Altman Z-score | 3.00 | — |
| CV checks passed | 11 of 11 | 10 of 11 |
| Employees | 46,000 | 140,800 |
Full résumé-style profiles: ENSG CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.